Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

University College London at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

University College London brings 12 presentations to ASH 2026 in New Orleans. Its research centres on CAR T-cell engineering and immune responses in myeloma. It includes a way to make allogeneic CAR-T cells without gene editing and long-read sequencing in a myeloma trial.

OrganizationASH 2026 Attendance
University College London
London, United Kingdom
Universities & research institutes
Public research university in London with large medical and life-sciences faculties.
Symposium
Fri Dec 11
3:00pm–6:00pm
Medical Crossfire®: Strategic Sequencing in ALL — From Asparaginase to Cellular Therapy in an MRD-Driven Era
Ordering acute lymphoblastic leukemia therapies, from asparaginase to bispecifics and CAR-T, guided by sensitive residual disease testing.
Leukemias
Session
Sun Dec 13
9:30am–10:45am
Through Space and Time: Spatiotemporal Organization of Haematopoiesis in Health and Disease
Blood stem cells do not share one uniform niche, and location, chromosome dosage, and body-wide feedback shape them in development, disease, and aging.
Blood biology

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University College London

Tell us what you sell and we’ll find the people at University College London most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction